Oryzon Genomics
BME:ORY
2,79
€-0,01 (-0,36%)
2,79
€-0,01 (-0,36%)
End-of-day quote: 04/09/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

€-0,06
Earnings Per Share
€0,00
Revenue Per Share
95,89%
Gross Margin %
€0,22 B
Market Cap
€0,01 B
Long-Term Debt
Earnings Per Share
€-0,06
Revenue Per Share
€0,00
Gross Margin %
95,89%
Market Cap
€0,22 B
Long-Term Debt
€0,01 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
EPS Earnings Per Share €-0,03 €-0,06 €-0,06 €-0,08 €-0,09 €-0,07 €-0,09 €-0,04 €-0,13 €-0,16
Earnings Earnings €-2,33M €-3,89M €-3,65M €-4,42M €-4,75M €-3,69M €-4,09M €-1,54M €-4,35M €-4,44M
RPS Revenue Per Share €0,00 €0,00 €0,00 €0,00 €0,00 €0,00 €0,00 €0,00 €0,18 €0,13 €0,18
Revenue Revenue €0,00M €0,00M €0,00M €0,00M €0,00M €0,00M €0,00M €0,00M €6,78M €4,32M €5,01M
OCF Operating Cash Flow €0,00M €-0,10M €-5,69M €-0,57M €-2,30M €-3,63M €0,00M €-3,93M €0,00M €0,00M €0,00M
FCF Free Cash Flow €0,00M €-12,25M €-13,40M €0,00M €0,00M €0,00M €0,00M €0,00M €0,00M €0,00M €0,00M
OM Operating Margin 0,00% -52,25% -61,18% -32,16% -35,02% -66,07% -45,06% -37,31% -47,73% -109,58% -98,81%
GM % Gross Margin % 0,00% 97,42% 95,89% 98,28% 97,04% 92,97% 94,47% 95,81% 95,68% 93,70% 92,59%
FCFS Free Cash Flow Per Share €0,00 €-0,17 €-0,21 €-0,25 €-0,29 €-0,29 €-0,27 €-0,30 €-0,20 €-0,28 €-0,34
LT Debt Long-Term Debt N/A €6,75M €7,42M €6,28M €10,27M €13,35M €8,68M €6,70M €9,98M €16,04M €17,72M
Sha. Stocks 79,89M 77,51M 64,75M 60,88M 55,29M 52,76M 52,76M 45,49M 38,45M 33,49M 27,72M
×